EE200100672A - Mono- ja diasendatud 3-propüül-gamma-aminovõihapped - Google Patents

Mono- ja diasendatud 3-propüül-gamma-aminovõihapped

Info

Publication number: EE200100672A
Authority: EE; Estonia
Prior art keywords: gamma; mono; propyl; substituted; butyric acids
Prior art date: 1999-06-10

Application number

EEP200100672A

Other languages

English (en)

Estonian (et)

Inventor

Richard Belliotti Thomas

Stephen Bryans Justin

David Wise Lawrence

Juergen Wustrow David

Victor Ekhato Ihoezo

Tobi Osuma Augustine

Michael Schelkun Robert

Bradley Schwarz Jacob

John Thorpe Andrew

Yuen Po-Wai

Original Assignee

Warner-Lambert Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-10

Filing date

2000-05-31

Publication date

2003-02-17

2000-05-31 Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company

2003-02-17 Publication of EE200100672A publication Critical patent/EE200100672A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/32—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EEP200100672A 1999-06-10 2000-05-31 Mono- ja diasendatud 3-propüül-gamma-aminovõihapped EE200100672A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13848599P	1999-06-10	1999-06-10
PCT/US2000/015070 WO2000076958A2 (en)	1999-06-10	2000-05-31	Mono- and disubstituted 3-propyl gamma-aminobutyric acids

Publications (1)

Publication Number	Publication Date
EE200100672A true EE200100672A (et)	2003-02-17

Family

ID=22482232

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100672A EE200100672A (et)	1999-06-10	2000-05-31	Mono- ja diasendatud 3-propüül-gamma-aminovõihapped

Country Status (43)

Country	Link
EP (1)	EP1192125B9 (es)
JP (1)	JP3904452B2 (es)
KR (1)	KR100694735B1 (es)
CN (2)	CN1196671C (es)
AP (1)	AP1397A (es)
AR (1)	AR033335A1 (es)
AT (1)	ATE419231T1 (es)
AU (1)	AU776723C (es)
BG (1)	BG65561B1 (es)
BR (1)	BR0011727A (es)
CA (2)	CA2689997A1 (es)
CO (1)	CO5200791A1 (es)
CR (1)	CR6529A (es)
CU (1)	CU23101A3 (es)
CY (1)	CY1108827T1 (es)
CZ (2)	CZ300834B6 (es)
DE (1)	DE60041256D1 (es)
DK (1)	DK1192125T3 (es)
DZ (1)	DZ3253A1 (es)
EA (1)	EA004398B1 (es)
EE (1)	EE200100672A (es)
ES (1)	ES2317839T3 (es)
GE (1)	GEP20074142B (es)
HK (2)	HK1046401B (es)
HR (1)	HRP20020025A2 (es)
HU (1)	HUP0201601A3 (es)
IL (2)	IL146969A0 (es)
IS (1)	IS6181A (es)
MA (1)	MA26804A1 (es)
ME (1)	MEP44808A (es)
MX (1)	MXPA01012319A (es)
NO (2)	NO327746B1 (es)
NZ (1)	NZ515668A (es)
OA (1)	OA11962A (es)
PE (1)	PE20010285A1 (es)
PT (1)	PT1192125E (es)
RS (2)	RS20090257A (es)
SI (1)	SI1192125T1 (es)
SK (2)	SK287399B6 (es)
TR (1)	TR200103587T2 (es)
UA (1)	UA72519C2 (es)
WO (1)	WO2000076958A2 (es)
ZA (1)	ZA200109711B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7164034B2 (en)	1999-06-10	2007-01-16	Pfizer Inc.	Alpha2delta ligands for fibromyalgia and other disorders
US6620829B2 (en) *	2000-10-17	2003-09-16	Warner-Lambert Company	Method of treating noninflammatory cartilage damage
AU2002345664C1 (en) *	2001-06-11	2008-03-06	Xenoport, Inc.	Prodrugs of gaba analogs, compositions and uses thereof
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
ITMI20011308A1 (it)	2001-06-21	2002-12-21	Nicox Sa	Farmaci per il dolore cronico
EP1469841A1 (en)	2002-01-31	2004-10-27	Warner-Lambert Company	Alpha 2 delta ligands to treat tinnitus
NI200300043A (es)	2002-03-28	2003-11-05	Warner Lambert Co	AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US20030225149A1 (en)	2002-04-30	2003-12-04	Blazecka Peter G.	Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
US7071339B2 (en)	2002-08-29	2006-07-04	Warner Lambert Company Llc	Process for preparing functionalized γ-butyrolactones from mucohalic acid
CA2451267A1 (en)	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
MXPA05006209A (es) *	2002-12-13	2005-08-19	Warner Lambert Co	Pregabalina y sus derivados para el tratamiento de fibromialgia y otros trastornos relacionados.
DK1572173T3 (da)	2002-12-13	2010-06-14	Warner Lambert Co	Alpha-2-delta-ligand til behandling af symptomer i den nedre urinvej
JP2006513257A (ja)	2002-12-13	2006-04-20	ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー	線維筋痛症および他の障害を処置するためのプレガバリン誘導体
ITMI20022658A1 (it)	2002-12-17	2004-06-18	Nicox Sa	Farmaci per il dolore cronico.
WO2005002585A1 (en) *	2003-07-02	2005-01-13	Warner-Lambert Company Llc	Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
AU2004271800A1 (en)	2003-09-12	2005-03-24	Pfizer Inc.	Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
MXPA06003395A (es) *	2003-09-25	2006-06-08	Warner Lambert Co	Aminoacidos con afinidad por la proteina a2d.
WO2005030703A1 (en)	2003-09-25	2005-04-07	Warner-Lambert Company Llc	PRODRUGS OF AMINO ACIDS WITH AFFINITY FOR THE α2δ- PROTEIN
WO2006043171A2 (en) *	2004-10-23	2006-04-27	Warner-Lambert Company Llc	Methods of using alpha2delta-1 selective compounds
ES2530398T3 (es) *	2005-09-15	2015-03-02	Ucb Pharma Sa	Pirrolidin-2-onas 4-sustituidas y su uso
US20070141684A1 (en) *	2005-12-21	2007-06-21	Pfizer Inc	Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
AR061728A1 (es) *	2006-06-30	2008-09-17	Pfizer Prod Inc	Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
ES2367881T3 (es)	2006-12-22	2011-11-10	Recordati Ireland Limited	Politerapia para trastornos de las vías urinarias inferiores con ligandos a2d y los aine.
WO2009136375A1 (en) *	2008-05-08	2009-11-12	Pfizer Inc	Treatment of interstitial cystitis
CA2783699C (en)	2009-12-08	2019-01-15	Case Western Reserve University	Primary amine compounds for treating ocular disorders
CN101914031B (zh) *	2010-07-30	2013-08-28	中国广州分析测试中心	普瑞巴林衍生物及其应用
KR102708250B1 (ko) *	2015-10-23	2024-09-23	나비토르 파마슈티칼스 인코포레이티드	세스트린-gator2 상호작용의 조절제 및 이의 용도
CN113164414A (zh)	2018-10-24	2021-07-23	纳维托制药有限公司	多晶型化合物和其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087544A (en) *	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) *	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
WO1992009560A1 (en) *	1990-11-27	1992-06-11	Northwestern University	Gaba and l-glutamic acid analogs for antiseizure treatment
ATE207052T1 (de) *	1992-05-20	2001-11-15	Univ Northwestern	Gaba und l-glutaminsaüre analoga zur behandlung der epilepsie
US5637767A (en) *	1995-06-07	1997-06-10	Warner-Lambert Company	Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
BR9710536A (pt) *	1996-07-24	1999-08-17	Warner Lambert Co	Isobutilgaba e seus derivados para o tratamento da dor
WO1998017627A1 (en) *	1996-10-23	1998-04-30	Warner-Lambert Company	Substituted gamma aminobutyric acids as pharmaceutical agents
CA2303244C (en) *	1997-10-27	2005-12-06	Warner-Lambert Company	Cyclic amino acids and derivatives thereof useful as pharmaceutical agents

2000
- 2000-05-31 RS RSP-2009/0257A patent/RS20090257A/sr unknown
- 2000-05-31 ES ES00938022T patent/ES2317839T3/es not_active Expired - Lifetime
- 2000-05-31 CA CA2689997A patent/CA2689997A1/en not_active Abandoned
- 2000-05-31 CN CNB00808730XA patent/CN1196671C/zh not_active Expired - Fee Related
- 2000-05-31 MX MXPA01012319A patent/MXPA01012319A/es active IP Right Grant
- 2000-05-31 EA EA200101134A patent/EA004398B1/ru not_active IP Right Cessation
- 2000-05-31 DK DK00938022T patent/DK1192125T3/da active
- 2000-05-31 CZ CZ20014285A patent/CZ300834B6/cs not_active IP Right Cessation
- 2000-05-31 CZ CZ20080760A patent/CZ301608B6/cs not_active IP Right Cessation
- 2000-05-31 UA UA2001128283A patent/UA72519C2/uk unknown
- 2000-05-31 AP APAP/P/2002/002388A patent/AP1397A/en active
- 2000-05-31 AT AT00938022T patent/ATE419231T1/de not_active IP Right Cessation
- 2000-05-31 WO PCT/US2000/015070 patent/WO2000076958A2/en active Application Filing
- 2000-05-31 EP EP00938022A patent/EP1192125B9/en not_active Expired - Lifetime
- 2000-05-31 GE GE4667A patent/GEP20074142B/en unknown
- 2000-05-31 ME MEP-448/08A patent/MEP44808A/xx unknown
- 2000-05-31 HU HU0201601A patent/HUP0201601A3/hu unknown
- 2000-05-31 TR TR2001/03587T patent/TR200103587T2/xx unknown
- 2000-05-31 DE DE60041256T patent/DE60041256D1/de not_active Expired - Lifetime
- 2000-05-31 IL IL14696900A patent/IL146969A0/xx active IP Right Grant
- 2000-05-31 EE EEP200100672A patent/EE200100672A/xx unknown
- 2000-05-31 SK SK5045-2009A patent/SK287399B6/sk not_active IP Right Cessation
- 2000-05-31 DZ DZ003253A patent/DZ3253A1/fr active
- 2000-05-31 SI SI200031015T patent/SI1192125T1/sl unknown
- 2000-05-31 JP JP2001503818A patent/JP3904452B2/ja not_active Expired - Fee Related
- 2000-05-31 PT PT00938022T patent/PT1192125E/pt unknown
- 2000-05-31 KR KR1020017015841A patent/KR100694735B1/ko not_active Expired - Fee Related
- 2000-05-31 CA CA2374755A patent/CA2374755C/en not_active Expired - Fee Related
- 2000-05-31 RS YUP-870/01A patent/RS50352B/sr unknown
- 2000-05-31 CN CNB2005100037011A patent/CN1310872C/zh not_active Expired - Fee Related
- 2000-05-31 OA OA1200100326A patent/OA11962A/en unknown
- 2000-05-31 SK SK1764-2001A patent/SK287247B6/sk not_active IP Right Cessation
- 2000-05-31 BR BR0011727-7A patent/BR0011727A/pt not_active IP Right Cessation
- 2000-05-31 NZ NZ515668A patent/NZ515668A/xx not_active IP Right Cessation
- 2000-05-31 AU AU53119/00A patent/AU776723C/en not_active Ceased
- 2000-06-07 AR ARP000102808A patent/AR033335A1/es active IP Right Grant
- 2000-06-09 CO CO00043067A patent/CO5200791A1/es not_active Application Discontinuation
- 2000-06-09 PE PE2000000577A patent/PE20010285A1/es not_active Application Discontinuation
2001
- 2001-11-26 ZA ZA200109711A patent/ZA200109711B/en unknown
- 2001-11-28 IS IS6181A patent/IS6181A/is unknown
- 2001-12-05 NO NO20015949A patent/NO327746B1/no not_active IP Right Cessation
- 2001-12-06 IL IL146969A patent/IL146969A/en not_active IP Right Cessation
- 2001-12-06 CU CU20010291A patent/CU23101A3/es not_active IP Right Cessation
- 2001-12-07 CR CR6529A patent/CR6529A/es not_active Application Discontinuation
2002
- 2002-01-02 MA MA26462A patent/MA26804A1/fr unknown
- 2002-01-09 BG BG106292A patent/BG65561B1/bg unknown
- 2002-01-10 HR HR20020025A patent/HRP20020025A2/hr not_active Application Discontinuation
- 2002-10-30 HK HK02107862.8A patent/HK1046401B/zh not_active IP Right Cessation
2005
- 2005-09-29 HK HK05108612A patent/HK1076626A1/xx not_active IP Right Cessation
2009
- 2009-02-26 CY CY20091100228T patent/CY1108827T1/el unknown
- 2009-03-13 NO NO20091094A patent/NO20091094L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL146969A (en)	2008-03-20
HK1076626A1 (en)	2006-01-20
UA72519C2 (en)	2005-03-15
AR033335A1 (es)	2003-12-17
CZ20014285A3 (cs)	2002-07-17
CA2374755A1 (en)	2000-12-21
CR6529A (es)	2003-11-25
HK1046401B (zh)	2005-12-02
NO327746B1 (no)	2009-09-14
JP3904452B2 (ja)	2007-04-11
KR20020009631A (ko)	2002-02-01
SK17642001A3 (sk)	2002-10-08
ZA200109711B (en)	2003-03-20
SI1192125T1 (sl)	2009-04-30
PT1192125E (pt)	2009-03-05
WO2000076958A3 (en)	2001-04-12
GEP20074142B (en)	2007-07-10
EP1192125B1 (en)	2008-12-31
KR100694735B1 (ko)	2007-03-14
WO2000076958A2 (en)	2000-12-21
MEP44808A (en)	2011-02-10
JP2003502308A (ja)	2003-01-21
CN1660779A (zh)	2005-08-31
AP1397A (en)	2005-04-19
DE60041256D1 (de)	2009-02-12
NO20091094L (no)	2001-12-05
YU87001A (sh)	2004-07-15
OA11962A (en)	2006-04-17
PE20010285A1 (es)	2001-03-22
BG65561B1 (bg)	2008-12-30
CZ300834B6 (cs)	2009-08-19
AU776723C (en)	2005-06-02
HK1046401A1 (en)	2003-01-10
ES2317839T3 (es)	2009-05-01
BR0011727A (pt)	2002-03-05
NZ515668A (en)	2004-02-27
TR200103587T2 (tr)	2002-04-22
EP1192125A2 (en)	2002-04-03
CA2374755C (en)	2010-03-30
AP2002002388A0 (en)	2002-03-31
NO20015949D0 (no)	2001-12-05
DK1192125T3 (da)	2009-02-16
AU5311900A (en)	2001-01-02
HUP0201601A2 (en)	2002-10-28
ATE419231T1 (de)	2009-01-15
MA26804A1 (fr)	2004-12-20
CY1108827T1 (el)	2014-04-09
HRP20020025A2 (en)	2003-12-31
BG106292A (en)	2002-05-31
CN1310872C (zh)	2007-04-18
AU776723B2 (en)	2004-09-16
HUP0201601A3 (en)	2002-11-28
CA2689997A1 (en)	2000-12-21
SK287399B6 (sk)	2010-08-09
CN1196671C (zh)	2005-04-13
IS6181A (is)	2001-11-28
CU23101A3 (es)	2005-12-20
DZ3253A1 (fr)	2000-12-21
EA200101134A1 (ru)	2002-06-27
RS20090257A (en)	2010-03-02
CO5200791A1 (es)	2002-09-27
MXPA01012319A (es)	2002-07-22
RS50352B (sr)	2009-11-10
NO20015949L (no)	2001-12-05
CZ301608B6 (cs)	2010-04-28
IL146969A0 (en)	2002-08-14
EP1192125B9 (en)	2009-09-16
EA004398B1 (ru)	2004-04-29
PL352431A1 (en)	2003-08-25
SK287247B6 (sk)	2010-04-07
CN1355784A (zh)	2002-06-26

Publication	Publication Date	Title
EE200100672A (et)	2003-02-17	Mono- ja diasendatud 3-propüül-gamma-aminovõihapped
NO2019016I1 (no)	2019-04-05	dasatinib
EE200000573A (et)	2002-04-15	Asendatud indoolalkaanhapped
DE69906203D1 (de)	2003-04-30	Carbonylierungsverfahren
ATE304361T1 (de)	2005-09-15	Immunstimulierende nukeinsäuren
PT1240172E (pt)	2005-02-28	Novos acidos aminopropilfosfinicos
DE50002558D1 (de)	2003-07-17	Rückspülfiltervorrichtung
ATE238984T1 (de)	2003-05-15	Sulfonylaminocarbonsäuren
DE50013969D1 (de)	2007-03-08	Querverbinder
DE69941635D1 (de)	2009-12-31	Abtastvorrichtung
DE60038253D1 (de)	2008-04-17	Verbindungsmaterial
DE60012691D1 (de)	2004-09-09	Diffusoreinheit
DE69916383D1 (de)	2004-05-19	Carbonylierungsverfahren
DK0928790T3 (da)	2003-06-30	Thiazolderivater
DE69906880D1 (de)	2003-05-22	Bilderzeugungsverfahren
DE59908990D1 (de)	2004-05-06	Radhausschale
FR2791348B1 (fr)	2007-10-05	POLYPEPTIDE Npt2B
DK1123283T3 (da)	2004-09-13	Thiazolderivater
NO984305D0 (no)	1998-09-17	Snekkemaskin
DE10018423B8 (de)	2007-03-29	Schiebedach
EP1192168A4 (en)	2003-04-16	galectin
DK0928793T3 (da)	2002-09-09	Thiazolderivater
DK1196366T3 (da)	2003-12-15	Carbonyleringsreaktioner
DE59906760D1 (de)	2003-10-02	Abtaster-steuereinrichtung
DE50003516D1 (de)	2003-10-09	Klebeverfahren

Legal Events

Date	Code	Title	Description
2004-10-15	HC1A	Change of owner name